Sarcoma

In this episode of the “CURE® Talks Cancer” podcast, Colin Jackson explains how he was able to complete a marathon even after cancer treatments that called for surgical removal of part of his femur, hip and surrounding muscle.

From a cancer survivor walking 3,000 miles for charity to a runner with cancer crossing the finish line with the help of her teammates, here’s what’s happening in the cancer landscape this week.

In this episode of the “CURE® Talks Cancer” podcast, Nicole Body discusses her cancer journey and shares how she found the strength to persevere through treatments and accept the difficult truths.

Finding the balance between offering support and guidance while at the same time not overwhelming people going through health scares isn’t easy, writes a cancer survivor. He notes that although it may take some practice to get right, it is an important skill for cancer thrivers to get down.

For the patient with a rare cancer, such as sarcoma, finding hope can be especially problematic, writes a cancer surgeon. Making patients hopeful, he writes, about their medical journey is as important as the medical components of treatment.

Navigating medical leave and insurance forms can be nerve-wracking and feel high stakes for some, writes a cancer survivor. Here, he offers advice on how to manage that stress.

An oncology nurse recalls how a young patient with Ewing sarcoma she helped care for taught her about bravery and being honest with patients. Here, she writes how he made her a better nurse.

From a high school track runner learning how to run again after a leg amputation due to bone cancer to a father adopting a healthier lifestyle to lose 115 pounds after losing his wife to ovarian cancer, here’s what’s happening in the cancer landscape this week.

Holding onto the anger that a cancer diagnosis provides can be a ruinous exercise, here's how one cancer fighter tries not to look back at his cancer with anger.

Physical and mental changes from your cancer treatment will be a natural occurrence, so don't take it personally.

From the recent discovery of osteosarcoma in a dinosaur bone to NFL player Nate Solder opting out of the upcoming season for health concerns, here’s what’s making headlines in the cancer space this week.

No longer were cancer fighters on another planet. We were right there with you, commiserating through the hardships and sharing the latest entertainment finds to help pass the time.

From the Food and Drug Administration asking pharmaceutical companies to voluntarily recall metformin, a type 2 diabetes medication, as it contains high levels of the cancer-causing contaminant NDMA to an NHL team’s fanbase showing support to a player as he finishes treatment for Ewing sarcoma, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved the first new treatment option for Kaposi sarcoma in more than 20 years.

I'm keeping hope alive that eventually, we'll get through the other side of the COVID-19 pandemic. One day at a time like anything else.

It's pretty clear that I have a lot of work ahead of me after years of devastation from cancer, but lately, I'm taking a new approach.

Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.

The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.

Having loved ones by your side is right up there in importance with any aspect of healing from cancer.

When we talk about stage 4 cancers, a lot of the time we hear about the disease spreading to the bones. It is important for us to understand that this is very different from cancer that originates in the bone.

Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer.

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Now a 10-year survivor of bone cancer, Dana Vaughns chose to triumph over his disease and joined Bristol-Myers Squibb on its Coast 2 Coast 4 Cancer ride.

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Where does hope lie when it comes to improving the treatment landscape for rare cancers?